Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Echocardiography | 45 | 2024 | 4989 | 3.750 |
Why?
|
Ventricular Function, Left | 25 | 2020 | 3879 | 2.420 |
Why?
|
Guideline Adherence | 18 | 2020 | 2220 | 2.320 |
Why?
|
Athletes | 21 | 2022 | 1137 | 2.230 |
Why?
|
Ventricular Remodeling | 20 | 2021 | 1267 | 2.220 |
Why?
|
Hypertrophy, Left Ventricular | 11 | 2017 | 851 | 2.000 |
Why?
|
Unnecessary Procedures | 6 | 2017 | 415 | 1.710 |
Why?
|
Heart Ventricles | 16 | 2021 | 3807 | 1.570 |
Why?
|
Physical Endurance | 11 | 2020 | 366 | 1.340 |
Why?
|
Cardiology Service, Hospital | 3 | 2017 | 239 | 1.310 |
Why?
|
Myocardial Contraction | 9 | 2019 | 1515 | 1.180 |
Why?
|
Cardiology | 9 | 2021 | 1656 | 1.040 |
Why?
|
Exercise | 13 | 2020 | 5890 | 1.030 |
Why?
|
Cardiac Imaging Techniques | 3 | 2017 | 267 | 0.970 |
Why?
|
Exercise Tolerance | 6 | 2019 | 836 | 0.940 |
Why?
|
Ventricular Dysfunction, Left | 10 | 2024 | 2118 | 0.850 |
Why?
|
Practice Guidelines as Topic | 11 | 2019 | 7390 | 0.790 |
Why?
|
Utilization Review | 4 | 2016 | 382 | 0.760 |
Why?
|
Cardiovascular Diseases | 13 | 2019 | 15500 | 0.750 |
Why?
|
Electrocardiography | 15 | 2021 | 6377 | 0.750 |
Why?
|
Heart Failure | 17 | 2023 | 11669 | 0.720 |
Why?
|
Adaptation, Physiological | 9 | 2020 | 1301 | 0.700 |
Why?
|
Heart | 9 | 2019 | 4404 | 0.660 |
Why?
|
Competitive Behavior | 2 | 2019 | 78 | 0.660 |
Why?
|
Heart Diseases | 8 | 2019 | 2781 | 0.650 |
Why?
|
Sports | 5 | 2017 | 705 | 0.550 |
Why?
|
Exercise Test | 9 | 2022 | 2127 | 0.550 |
Why?
|
Echocardiography, Stress | 2 | 2016 | 134 | 0.530 |
Why?
|
Hospitalization | 6 | 2023 | 10723 | 0.520 |
Why?
|
Coronary Aneurysm | 1 | 2018 | 232 | 0.510 |
Why?
|
Quality Indicators, Health Care | 3 | 2019 | 1792 | 0.510 |
Why?
|
Physical Fitness | 5 | 2021 | 743 | 0.500 |
Why?
|
Syncope | 1 | 2018 | 427 | 0.500 |
Why?
|
Saphenous Vein | 1 | 2018 | 516 | 0.500 |
Why?
|
Endocardium | 1 | 2016 | 248 | 0.490 |
Why?
|
Athletic Performance | 1 | 2015 | 111 | 0.460 |
Why?
|
Football | 3 | 2016 | 503 | 0.460 |
Why?
|
Coronary Artery Disease | 8 | 2023 | 6403 | 0.450 |
Why?
|
Clinical Trials as Topic | 3 | 2017 | 8002 | 0.450 |
Why?
|
Natriuretic Peptide, Brain | 7 | 2017 | 1723 | 0.440 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2015 | 241 | 0.440 |
Why?
|
Physical Exertion | 2 | 2019 | 667 | 0.430 |
Why?
|
Tricuspid Valve | 1 | 2016 | 410 | 0.430 |
Why?
|
Death, Sudden, Cardiac | 5 | 2016 | 1555 | 0.430 |
Why?
|
Coronary Vasospasm | 2 | 2023 | 81 | 0.430 |
Why?
|
Patient Selection | 5 | 2014 | 4244 | 0.430 |
Why?
|
Mass Screening | 5 | 2012 | 5428 | 0.420 |
Why?
|
Academic Medical Centers | 5 | 2019 | 2759 | 0.420 |
Why?
|
Oxygen Consumption | 7 | 2022 | 1866 | 0.420 |
Why?
|
Stroke Volume | 15 | 2023 | 5496 | 0.410 |
Why?
|
Education, Medical | 2 | 2015 | 1725 | 0.400 |
Why?
|
Ambulatory Care | 4 | 2015 | 2775 | 0.400 |
Why?
|
Cardiomyopathy, Hypertrophic | 3 | 2019 | 1310 | 0.400 |
Why?
|
Endocarditis | 1 | 2016 | 348 | 0.390 |
Why?
|
Pericardium | 1 | 2016 | 675 | 0.390 |
Why?
|
Running | 4 | 2020 | 488 | 0.390 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2013 | 219 | 0.370 |
Why?
|
Quality Improvement | 3 | 2017 | 3801 | 0.370 |
Why?
|
Hand Strength | 2 | 2019 | 456 | 0.360 |
Why?
|
Torsion Abnormality | 1 | 2010 | 91 | 0.350 |
Why?
|
Humans | 117 | 2024 | 761504 | 0.340 |
Why?
|
Exercise Therapy | 2 | 2019 | 929 | 0.340 |
Why?
|
Heat-Shock Response | 1 | 2011 | 179 | 0.340 |
Why?
|
Peptide Fragments | 7 | 2017 | 5112 | 0.340 |
Why?
|
Fibromuscular Dysplasia | 1 | 2009 | 55 | 0.330 |
Why?
|
Coronary Artery Bypass | 2 | 2018 | 2188 | 0.330 |
Why?
|
Echocardiography, Doppler | 8 | 2019 | 897 | 0.330 |
Why?
|
Myocardial Perfusion Imaging | 3 | 2023 | 575 | 0.320 |
Why?
|
Male | 80 | 2024 | 360804 | 0.320 |
Why?
|
Medical Staff, Hospital | 1 | 2013 | 601 | 0.320 |
Why?
|
Renal Artery Obstruction | 1 | 2009 | 219 | 0.310 |
Why?
|
Sodium Chloride | 1 | 2010 | 587 | 0.300 |
Why?
|
Crack Cocaine | 1 | 2008 | 32 | 0.300 |
Why?
|
Fee-for-Service Plans | 1 | 2013 | 700 | 0.300 |
Why?
|
Sports Medicine | 3 | 2017 | 240 | 0.300 |
Why?
|
Blood Pressure | 7 | 2019 | 8481 | 0.300 |
Why?
|
Weight Lifting | 3 | 2017 | 130 | 0.290 |
Why?
|
Arteries | 1 | 2012 | 1123 | 0.280 |
Why?
|
Androgens | 4 | 2017 | 1286 | 0.280 |
Why?
|
Attitude of Health Personnel | 3 | 2016 | 3889 | 0.280 |
Why?
|
Brugada Syndrome | 1 | 2008 | 93 | 0.280 |
Why?
|
Advisory Committees | 1 | 2011 | 787 | 0.270 |
Why?
|
Echocardiography, Doppler, Color | 4 | 2012 | 352 | 0.270 |
Why?
|
Ontario | 5 | 2019 | 398 | 0.270 |
Why?
|
Cardiovascular Agents | 1 | 2012 | 840 | 0.270 |
Why?
|
American Heart Association | 1 | 2011 | 1039 | 0.260 |
Why?
|
Rest | 1 | 2011 | 918 | 0.260 |
Why?
|
Prospective Studies | 26 | 2022 | 54425 | 0.260 |
Why?
|
Students | 2 | 2013 | 1741 | 0.260 |
Why?
|
Testosterone Congeners | 2 | 2017 | 62 | 0.260 |
Why?
|
Anabolic Agents | 3 | 2015 | 256 | 0.260 |
Why?
|
Risk Assessment | 12 | 2024 | 23995 | 0.240 |
Why?
|
Heart Rate | 5 | 2019 | 4195 | 0.240 |
Why?
|
Cocaine-Related Disorders | 1 | 2008 | 461 | 0.230 |
Why?
|
Female | 61 | 2024 | 392644 | 0.230 |
Why?
|
Single-Blind Method | 3 | 2017 | 1572 | 0.220 |
Why?
|
Doping in Sports | 2 | 2017 | 62 | 0.220 |
Why?
|
Longitudinal Studies | 12 | 2020 | 14605 | 0.220 |
Why?
|
Health Resources | 2 | 2019 | 935 | 0.220 |
Why?
|
Hemodynamics | 2 | 2019 | 4159 | 0.210 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 2 | 2014 | 208 | 0.210 |
Why?
|
Point-of-Care Systems | 1 | 2012 | 1213 | 0.210 |
Why?
|
Boston | 5 | 2014 | 9326 | 0.210 |
Why?
|
Hospital Mortality | 2 | 2016 | 5294 | 0.210 |
Why?
|
Rotation | 2 | 2016 | 517 | 0.210 |
Why?
|
Predictive Value of Tests | 11 | 2021 | 15266 | 0.200 |
Why?
|
Patient Readmission | 3 | 2023 | 3270 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3204 | 0.200 |
Why?
|
Galectin 3 | 2 | 2015 | 240 | 0.200 |
Why?
|
Outpatients | 5 | 2021 | 1597 | 0.200 |
Why?
|
Patient Care Team | 1 | 2013 | 2521 | 0.190 |
Why?
|
Clinical Competence | 3 | 2017 | 4792 | 0.190 |
Why?
|
Gastroplasty | 1 | 2003 | 157 | 0.190 |
Why?
|
Diastole | 4 | 2017 | 782 | 0.190 |
Why?
|
Research Design | 1 | 2017 | 6180 | 0.180 |
Why?
|
Prognosis | 13 | 2024 | 29625 | 0.180 |
Why?
|
Young Adult | 21 | 2021 | 59243 | 0.180 |
Why?
|
Troponin I | 2 | 2015 | 651 | 0.170 |
Why?
|
Hospitals | 2 | 2023 | 3882 | 0.170 |
Why?
|
Time Factors | 17 | 2020 | 39967 | 0.170 |
Why?
|
Radiology | 1 | 2014 | 2113 | 0.170 |
Why?
|
Middle Aged | 40 | 2022 | 220895 | 0.170 |
Why?
|
Pulmonary Gas Exchange | 2 | 2019 | 379 | 0.170 |
Why?
|
Societies, Medical | 1 | 2011 | 3905 | 0.160 |
Why?
|
Soccer | 1 | 2021 | 142 | 0.160 |
Why?
|
Cardiac Output | 2 | 2019 | 831 | 0.150 |
Why?
|
Coronary Occlusion | 1 | 2021 | 304 | 0.150 |
Why?
|
Swimming | 1 | 2019 | 208 | 0.150 |
Why?
|
Obesity, Morbid | 2 | 2013 | 1277 | 0.150 |
Why?
|
Atrial Appendage | 1 | 2021 | 283 | 0.150 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2010 | 3357 | 0.150 |
Why?
|
Ultrasonography | 6 | 2012 | 5972 | 0.140 |
Why?
|
Aged | 27 | 2023 | 169289 | 0.140 |
Why?
|
Ventricular Function, Right | 5 | 2016 | 617 | 0.140 |
Why?
|
Performance-Enhancing Substances | 1 | 2017 | 30 | 0.140 |
Why?
|
Adult | 32 | 2022 | 221177 | 0.140 |
Why?
|
Coronary Vessels | 3 | 2018 | 3096 | 0.130 |
Why?
|
Pressure | 1 | 2019 | 1154 | 0.130 |
Why?
|
Follow-Up Studies | 13 | 2020 | 39106 | 0.130 |
Why?
|
Norepinephrine | 1 | 2019 | 897 | 0.130 |
Why?
|
Medicare | 2 | 2018 | 6770 | 0.130 |
Why?
|
Cardiomyopathies | 2 | 2022 | 1964 | 0.130 |
Why?
|
Bundle-Branch Block | 2 | 2011 | 276 | 0.130 |
Why?
|
Heart Failure, Systolic | 1 | 2017 | 135 | 0.130 |
Why?
|
Amyloidosis | 1 | 2022 | 817 | 0.130 |
Why?
|
Endothelin-1 | 1 | 2017 | 302 | 0.130 |
Why?
|
Epinephrine | 1 | 2019 | 792 | 0.120 |
Why?
|
Hypotension, Orthostatic | 1 | 2018 | 258 | 0.120 |
Why?
|
Systole | 5 | 2017 | 936 | 0.120 |
Why?
|
General Practitioners | 1 | 2016 | 101 | 0.120 |
Why?
|
Liability, Legal | 1 | 2016 | 210 | 0.120 |
Why?
|
Hypertension | 5 | 2019 | 8540 | 0.120 |
Why?
|
Naval Medicine | 1 | 2014 | 30 | 0.120 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3358 | 0.120 |
Why?
|
Beneficence | 1 | 1994 | 54 | 0.120 |
Why?
|
Massachusetts | 3 | 2016 | 8830 | 0.120 |
Why?
|
Ethics | 1 | 1994 | 94 | 0.120 |
Why?
|
Aortic Diseases | 1 | 2020 | 735 | 0.110 |
Why?
|
Societies | 1 | 1994 | 108 | 0.110 |
Why?
|
Retrospective Studies | 14 | 2023 | 80636 | 0.110 |
Why?
|
Moral Obligations | 1 | 1994 | 93 | 0.110 |
Why?
|
Heart Failure, Diastolic | 1 | 2014 | 76 | 0.110 |
Why?
|
Diagnosis, Differential | 4 | 2018 | 12974 | 0.110 |
Why?
|
Hypopituitarism | 1 | 2015 | 250 | 0.110 |
Why?
|
Feedback | 2 | 2017 | 791 | 0.110 |
Why?
|
Lanthanum | 1 | 2013 | 30 | 0.110 |
Why?
|
Phosphorus, Dietary | 1 | 2013 | 20 | 0.110 |
Why?
|
Myocardium | 2 | 2017 | 4726 | 0.110 |
Why?
|
Chest Pain | 2 | 2018 | 1091 | 0.110 |
Why?
|
Aged, 80 and over | 9 | 2023 | 58976 | 0.110 |
Why?
|
Risk Factors | 13 | 2017 | 74206 | 0.110 |
Why?
|
Pyrazoles | 1 | 2023 | 2009 | 0.110 |
Why?
|
Arrhythmias, Cardiac | 2 | 2014 | 2244 | 0.110 |
Why?
|
Blood Pressure Determination | 2 | 2014 | 633 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 4 | 2016 | 6484 | 0.110 |
Why?
|
Acromegaly | 1 | 2015 | 310 | 0.100 |
Why?
|
Heart Valve Diseases | 1 | 2020 | 1027 | 0.100 |
Why?
|
Altruism | 1 | 1994 | 208 | 0.100 |
Why?
|
Preventive Health Services | 1 | 2017 | 567 | 0.100 |
Why?
|
Cardiac Volume | 2 | 2010 | 197 | 0.100 |
Why?
|
United States | 13 | 2021 | 72334 | 0.100 |
Why?
|
Aorta | 2 | 2020 | 2042 | 0.100 |
Why?
|
Tendon Injuries | 1 | 2015 | 328 | 0.100 |
Why?
|
Social Responsibility | 1 | 1994 | 386 | 0.100 |
Why?
|
False Positive Reactions | 2 | 2011 | 957 | 0.100 |
Why?
|
Laparoscopy | 1 | 2003 | 2035 | 0.090 |
Why?
|
Chelating Agents | 1 | 2013 | 387 | 0.090 |
Why?
|
Adolescent | 14 | 2021 | 88319 | 0.090 |
Why?
|
Torsion, Mechanical | 1 | 2010 | 15 | 0.090 |
Why?
|
National Health Programs | 1 | 1994 | 440 | 0.090 |
Why?
|
Equipment Safety | 1 | 2012 | 249 | 0.090 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20098 | 0.090 |
Why?
|
Torque | 1 | 2011 | 133 | 0.090 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2010 | 69 | 0.090 |
Why?
|
Human Growth Hormone | 1 | 2015 | 642 | 0.090 |
Why?
|
Learning Curve | 1 | 2012 | 230 | 0.090 |
Why?
|
Hormone Replacement Therapy | 1 | 2015 | 751 | 0.090 |
Why?
|
Purines | 2 | 2023 | 607 | 0.090 |
Why?
|
Reminder Systems | 1 | 2013 | 388 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2015 | 4016 | 0.080 |
Why?
|
Phosphates | 1 | 2013 | 770 | 0.080 |
Why?
|
Cross-Sectional Studies | 11 | 2021 | 26125 | 0.080 |
Why?
|
Treatment Outcome | 13 | 2019 | 64680 | 0.080 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2011 | 261 | 0.080 |
Why?
|
Troponin T | 1 | 2014 | 780 | 0.080 |
Why?
|
Disease Progression | 6 | 2015 | 13506 | 0.080 |
Why?
|
Algorithms | 2 | 2020 | 14031 | 0.080 |
Why?
|
Hypogonadism | 1 | 2015 | 798 | 0.080 |
Why?
|
Gastrectomy | 1 | 2013 | 672 | 0.080 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2015 | 1050 | 0.080 |
Why?
|
Radiation Dosage | 1 | 2017 | 1958 | 0.080 |
Why?
|
Alcohol-Induced Disorders | 1 | 2008 | 27 | 0.080 |
Why?
|
Resistance Training | 1 | 2010 | 193 | 0.080 |
Why?
|
Physicians | 2 | 2017 | 4591 | 0.080 |
Why?
|
Renal Artery | 1 | 2009 | 351 | 0.070 |
Why?
|
Universities | 1 | 2013 | 993 | 0.070 |
Why?
|
Weight Loss | 2 | 2013 | 2684 | 0.070 |
Why?
|
Thrombosis | 1 | 2021 | 2942 | 0.070 |
Why?
|
Pulmonary Artery | 1 | 2016 | 1927 | 0.070 |
Why?
|
Fibroblast Growth Factors | 1 | 2013 | 867 | 0.070 |
Why?
|
Aortic Valve Insufficiency | 1 | 2011 | 576 | 0.070 |
Why?
|
Germany | 2 | 2013 | 875 | 0.070 |
Why?
|
Incidence | 4 | 2016 | 21353 | 0.070 |
Why?
|
Ventricular Fibrillation | 1 | 2009 | 537 | 0.070 |
Why?
|
Community Health Services | 1 | 2012 | 656 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2017 | 2882 | 0.070 |
Why?
|
Reference Values | 2 | 2011 | 4920 | 0.070 |
Why?
|
Hemangiosarcoma | 1 | 1989 | 215 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1651 | 0.070 |
Why?
|
Health Services for the Aged | 1 | 2009 | 259 | 0.070 |
Why?
|
Critical Care | 1 | 2019 | 2696 | 0.070 |
Why?
|
Chronic Disease | 6 | 2019 | 9318 | 0.060 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2219 | 0.060 |
Why?
|
Health Care Reform | 1 | 1994 | 1247 | 0.060 |
Why?
|
Hypertension, Pulmonary | 1 | 2016 | 1578 | 0.060 |
Why?
|
Gastric Bypass | 1 | 2013 | 818 | 0.060 |
Why?
|
Acute Coronary Syndrome | 1 | 2018 | 2190 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3688 | 0.060 |
Why?
|
Pediatrics | 2 | 2017 | 3589 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2373 | 0.060 |
Why?
|
Odds Ratio | 5 | 2015 | 9646 | 0.060 |
Why?
|
Europe | 1 | 2011 | 3422 | 0.060 |
Why?
|
Observer Variation | 1 | 2010 | 2606 | 0.060 |
Why?
|
Angiography | 1 | 2009 | 1595 | 0.060 |
Why?
|
Vectorcardiography | 1 | 1983 | 48 | 0.060 |
Why?
|
Telemedicine | 1 | 2021 | 3051 | 0.060 |
Why?
|
Equipment Design | 1 | 2012 | 3510 | 0.060 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2011 | 1496 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2014 | 2113 | 0.050 |
Why?
|
Pandemics | 2 | 2021 | 8654 | 0.050 |
Why?
|
Substance-Related Disorders | 2 | 2017 | 4420 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2020 | 4811 | 0.050 |
Why?
|
Quality Control | 2 | 2016 | 832 | 0.050 |
Why?
|
Quality of Life | 2 | 2011 | 13367 | 0.050 |
Why?
|
Heart Defects, Congenital | 2 | 2017 | 4671 | 0.050 |
Why?
|
Organ Transplantation | 1 | 2013 | 1157 | 0.050 |
Why?
|
Registries | 4 | 2022 | 8224 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2009 | 1725 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2010 | 6228 | 0.050 |
Why?
|
Pilot Projects | 1 | 2015 | 8631 | 0.050 |
Why?
|
Pulse | 1 | 2021 | 217 | 0.050 |
Why?
|
Inpatients | 1 | 2013 | 2548 | 0.050 |
Why?
|
Ultrasonography, Interventional | 1 | 2009 | 1496 | 0.050 |
Why?
|
Pregnancy | 1 | 2003 | 29874 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2012 | 5247 | 0.050 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2011 | 1553 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2003 | 15631 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2021 | 3769 | 0.040 |
Why?
|
Tachycardia, Ventricular | 1 | 2009 | 1304 | 0.040 |
Why?
|
Delivery of Health Care | 2 | 2017 | 5336 | 0.040 |
Why?
|
Gorilla gorilla | 1 | 2019 | 29 | 0.040 |
Why?
|
Case-Control Studies | 5 | 2017 | 22176 | 0.040 |
Why?
|
Prevalence | 2 | 2014 | 15732 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3245 | 0.040 |
Why?
|
Pan troglodytes | 1 | 2019 | 223 | 0.040 |
Why?
|
Diuretics | 2 | 2013 | 610 | 0.040 |
Why?
|
Severity of Illness Index | 5 | 2016 | 15842 | 0.040 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2019 | 186 | 0.040 |
Why?
|
Fibrin | 1 | 2021 | 507 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2013 | 2243 | 0.040 |
Why?
|
Dilatation, Pathologic | 1 | 2020 | 527 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2023 | 1068 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7879 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2017 | 12463 | 0.040 |
Why?
|
Logistic Models | 1 | 2012 | 13255 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12059 | 0.030 |
Why?
|
Medical History Taking | 2 | 2010 | 774 | 0.030 |
Why?
|
Aspartate Aminotransferases | 1 | 2017 | 416 | 0.030 |
Why?
|
Myocardial Infarction | 2 | 2009 | 11460 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2013 | 1516 | 0.030 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2016 | 103 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 10209 | 0.030 |
Why?
|
Species Specificity | 1 | 2019 | 2414 | 0.030 |
Why?
|
Pennsylvania | 1 | 2016 | 613 | 0.030 |
Why?
|
MicroRNAs | 1 | 2011 | 3816 | 0.030 |
Why?
|
Coronary Angiography | 3 | 2017 | 4471 | 0.030 |
Why?
|
Antihypertensive Agents | 2 | 2016 | 2024 | 0.030 |
Why?
|
American Medical Association | 1 | 1994 | 60 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2017 | 603 | 0.030 |
Why?
|
Ships | 1 | 2014 | 53 | 0.030 |
Why?
|
Reference Standards | 1 | 2018 | 1003 | 0.030 |
Why?
|
Rupture | 1 | 2015 | 443 | 0.030 |
Why?
|
Economics | 1 | 1994 | 141 | 0.030 |
Why?
|
Aortic Valve | 2 | 2020 | 1955 | 0.030 |
Why?
|
Atrial Function, Left | 1 | 2015 | 185 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 1989 | 3164 | 0.030 |
Why?
|
Radiology Information Systems | 1 | 2018 | 529 | 0.030 |
Why?
|
Splenic Neoplasms | 1 | 1994 | 94 | 0.030 |
Why?
|
Immunoassay | 1 | 2017 | 745 | 0.030 |
Why?
|
Professional Autonomy | 1 | 1994 | 171 | 0.030 |
Why?
|
Databases, Factual | 2 | 2019 | 7967 | 0.030 |
Why?
|
Positron-Emission Tomography | 2 | 2021 | 6485 | 0.030 |
Why?
|
Linear Models | 2 | 2016 | 5871 | 0.030 |
Why?
|
Health Planning | 1 | 1994 | 230 | 0.030 |
Why?
|
Medical Records | 1 | 2018 | 1408 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 4 | 2021 | 20570 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2013 | 369 | 0.030 |
Why?
|
Organizational Policy | 1 | 1994 | 432 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 1989 | 4249 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2016 | 973 | 0.020 |
Why?
|
Creatinine | 1 | 2017 | 1899 | 0.020 |
Why?
|
Florida | 1 | 2013 | 431 | 0.020 |
Why?
|
Lisinopril | 1 | 2011 | 61 | 0.020 |
Why?
|
Atrial Function, Right | 1 | 2011 | 32 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36426 | 0.020 |
Why?
|
Furosemide | 1 | 2011 | 170 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1611 | 0.020 |
Why?
|
Models, Cardiovascular | 1 | 2016 | 981 | 0.020 |
Why?
|
Galectins | 1 | 2013 | 295 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2122 | 0.020 |
Why?
|
Social Justice | 1 | 1994 | 478 | 0.020 |
Why?
|
Heart Septum | 1 | 2011 | 301 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2015 | 2927 | 0.020 |
Why?
|
Phenotype | 2 | 2019 | 16591 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2014 | 1186 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2016 | 2426 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14666 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 3416 | 0.020 |
Why?
|
Emergency Medicine | 1 | 2018 | 1198 | 0.020 |
Why?
|
Protein Precursors | 1 | 2012 | 1132 | 0.020 |
Why?
|
Cardiomegaly | 1 | 2011 | 590 | 0.020 |
Why?
|
Blood Proteins | 1 | 2013 | 1173 | 0.020 |
Why?
|
Standard of Care | 1 | 2011 | 551 | 0.020 |
Why?
|
Age Factors | 3 | 2015 | 18395 | 0.020 |
Why?
|
Remission Induction | 1 | 2013 | 2396 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2015 | 2696 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2013 | 1241 | 0.020 |
Why?
|
Lymphocytes | 1 | 1994 | 2612 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 2358 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9610 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 2919 | 0.020 |
Why?
|
Cohort Studies | 3 | 2015 | 41487 | 0.020 |
Why?
|
Plaque, Atherosclerotic | 1 | 2017 | 1533 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2019 | 3745 | 0.020 |
Why?
|
Body Mass Index | 1 | 2003 | 12953 | 0.020 |
Why?
|
Postoperative Hemorrhage | 1 | 2009 | 415 | 0.020 |
Why?
|
Emergency Treatment | 1 | 2009 | 496 | 0.020 |
Why?
|
Heart Atria | 1 | 2011 | 1345 | 0.010 |
Why?
|
Probability | 1 | 2010 | 2477 | 0.010 |
Why?
|
Lymphoma | 1 | 1994 | 1901 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2850 | 0.010 |
Why?
|
Child | 3 | 2017 | 80153 | 0.010 |
Why?
|
Testosterone | 1 | 2015 | 2472 | 0.010 |
Why?
|
Curriculum | 1 | 2017 | 3743 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2014 | 2639 | 0.010 |
Why?
|
Software | 1 | 2018 | 4434 | 0.010 |
Why?
|
Physical Examination | 1 | 2010 | 1255 | 0.010 |
Why?
|
Lipids | 1 | 2015 | 3341 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3600 | 0.010 |
Why?
|
Shock, Cardiogenic | 1 | 2009 | 709 | 0.010 |
Why?
|
Sex Factors | 2 | 2015 | 10552 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2016 | 12341 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8529 | 0.010 |
Why?
|
Body Weight | 2 | 2008 | 4618 | 0.010 |
Why?
|
Defibrillators, Implantable | 1 | 2009 | 1490 | 0.010 |
Why?
|
Biopsy | 1 | 2011 | 6766 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2014 | 4948 | 0.010 |
Why?
|
Comorbidity | 1 | 2013 | 10508 | 0.010 |
Why?
|
Survival Rate | 1 | 2012 | 12725 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10766 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 2009 | 1924 | 0.010 |
Why?
|
Aortic Aneurysm | 1 | 1980 | 648 | 0.010 |
Why?
|
Child, Preschool | 1 | 2016 | 42230 | 0.010 |
Why?
|
Coronary Disease | 1 | 1988 | 5914 | 0.010 |
Why?
|
Splenomegaly | 1 | 1994 | 189 | 0.010 |
Why?
|
Aging | 1 | 2012 | 8708 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1994 | 698 | 0.010 |
Why?
|
Heart Valve Prosthesis | 1 | 1980 | 1462 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1994 | 2561 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1994 | 1596 | 0.010 |
Why?
|
Cytoplasm | 1 | 1994 | 1510 | 0.010 |
Why?
|
Fatal Outcome | 1 | 1994 | 1834 | 0.010 |
Why?
|
Immunophenotyping | 1 | 1994 | 1870 | 0.000 |
Why?
|
Diatrizoate | 1 | 1988 | 81 | 0.000 |
Why?
|
Diatrizoate Meglumine | 1 | 1988 | 79 | 0.000 |
Why?
|
Spleen | 1 | 1994 | 2295 | 0.000 |
Why?
|
Animals | 1 | 2019 | 168459 | 0.000 |
Why?
|
Cell Nucleus | 1 | 1994 | 2909 | 0.000 |
Why?
|
Parenteral Nutrition, Total | 1 | 1985 | 304 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1994 | 5869 | 0.000 |
Why?
|
Drug Combinations | 1 | 1988 | 2048 | 0.000 |
Why?
|
Random Allocation | 1 | 1985 | 2395 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1985 | 13380 | 0.000 |
Why?
|
Polyethylene Terephthalates | 1 | 1980 | 113 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1994 | 11076 | 0.000 |
Why?
|
Dietary Proteins | 1 | 1985 | 952 | 0.000 |
Why?
|
Heart Arrest, Induced | 1 | 1980 | 358 | 0.000 |
Why?
|
Eating | 1 | 1985 | 1539 | 0.000 |
Why?
|
Blood Vessel Prosthesis | 1 | 1980 | 952 | 0.000 |
Why?
|
Contrast Media | 1 | 1988 | 5311 | 0.000 |
Why?
|
Radiography | 1 | 1980 | 6965 | 0.000 |
Why?
|